retatrutide triple agonist gip glp-1 glucagon receptor π¨ HOT OFF THE PRESS: Phase 3 data has arrived β and the obesity medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Retatrutide: How Triple GLP-1/GIP/Glucagon Receptor
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 1 - Aug 6



























